SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-004687
Filing Date
2021-02-08
Accepted
2021-02-08 16:05:49
Documents
57
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q onvo-10q_20201231.htm 10-Q 1883901
2 EX-10.1 onvo-ex101_11.htm EX-10.1 27367
3 EX-31.1 onvo-ex311_7.htm EX-31.1 9443
4 EX-31.2 onvo-ex312_6.htm EX-31.2 9469
5 EX-32.1 onvo-ex321_10.htm EX-32.1 9077
6 GRAPHIC g0maazjunfwa000001.jpg GRAPHIC 21332
  Complete submission text file 0001564590-21-004687.txt   5650436

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT onvo-20201231.xml EX-101.INS 957091
8 XBRL TAXONOMY EXTENSION SCHEMA onvo-20201231.xsd EX-101.SCH 44747
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onvo-20201231_cal.xml EX-101.CAL 29093
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onvo-20201231_def.xml EX-101.DEF 166941
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE onvo-20201231_lab.xml EX-101.LAB 345338
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onvo-20201231_pre.xml EX-101.PRE 280959
Mailing Address 440 STEVENS AVENUE, SUITE 200 SOLANA BEACH CA 92075
Business Address 440 STEVENS AVENUE, SUITE 200 SOLANA BEACH CA 92075 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

IRS No.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 21601449
SIC: 2836 Biological Products, (No Diagnostic Substances)